These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 27033685)

  • 1. Complex interplay between brain function and structure during cerebral amyloidosis in APP transgenic mouse strains revealed by multi-parametric MRI comparison.
    Grandjean J; Derungs R; Kulic L; Welt T; Henkelman M; Nitsch RM; Rudin M
    Neuroimage; 2016 Jul; 134():1-11. PubMed ID: 27033685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multimodal Imaging in Rat Model Recapitulates Alzheimer's Disease Biomarkers Abnormalities.
    Parent MJ; Zimmer ER; Shin M; Kang MS; Fonov VS; Mathieu A; Aliaga A; Kostikov A; Do Carmo S; Dea D; Poirier J; Soucy JP; Gauthier S; Cuello AC; Rosa-Neto P
    J Neurosci; 2017 Dec; 37(50):12263-12271. PubMed ID: 29097597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased soluble amyloid-beta causes early aberrant brain network hypersynchronisation in a mature-onset mouse model of amyloidosis.
    Ben-Nejma IRH; Keliris AJ; Daans J; Ponsaerts P; Verhoye M; Van der Linden A; Keliris GA
    Acta Neuropathol Commun; 2019 Nov; 7(1):180. PubMed ID: 31727182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longitudinal regional brain volume changes quantified in normal aging and Alzheimer's APP x PS1 mice using MRI.
    Maheswaran S; Barjat H; Rueckert D; Bate ST; Howlett DR; Tilling L; Smart SC; Pohlmann A; Richardson JC; Hartkens T; Hill DL; Upton N; Hajnal JV; James MF
    Brain Res; 2009 May; 1270():19-32. PubMed ID: 19272356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early functional connectivity deficits and progressive microstructural alterations in the TgF344-AD rat model of Alzheimer's Disease: A longitudinal MRI study.
    Anckaerts C; Blockx I; Summer P; Michael J; Hamaide J; Kreutzer C; Boutin H; Couillard-Després S; Verhoye M; Van der Linden A
    Neurobiol Dis; 2019 Apr; 124():93-107. PubMed ID: 30445024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dispersible amyloid β-protein oligomers, protofibrils, and fibrils represent diffusible but not soluble aggregates: their role in neurodegeneration in amyloid precursor protein (APP) transgenic mice.
    Rijal Upadhaya A; Capetillo-Zarate E; Kosterin I; Abramowski D; Kumar S; Yamaguchi H; Walter J; Fändrich M; Staufenbiel M; Thal DR
    Neurobiol Aging; 2012 Nov; 33(11):2641-60. PubMed ID: 22305478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deposition of mouse amyloid beta in human APP/PS1 double and single AD model transgenic mice.
    van Groen T; Kiliaan AJ; Kadish I
    Neurobiol Dis; 2006 Sep; 23(3):653-62. PubMed ID: 16829076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Restricted diffusion in the brain of transgenic mice with cerebral amyloidosis.
    Mueggler T; Meyer-Luehmann M; Rausch M; Staufenbiel M; Jucker M; Rudin M
    Eur J Neurosci; 2004 Aug; 20(3):811-7. PubMed ID: 15255991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intraneuronal amyloid beta and reduced brain volume in a novel APP T714I mouse model for Alzheimer's disease.
    Van Broeck B; Vanhoutte G; Pirici D; Van Dam D; Wils H; Cuijt I; Vennekens K; Zabielski M; Michalik A; Theuns J; De Deyn PP; Van der Linden A; Van Broeckhoven C; Kumar-Singh S
    Neurobiol Aging; 2008 Feb; 29(2):241-52. PubMed ID: 17112635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repetitive mild brain trauma accelerates Abeta deposition, lipid peroxidation, and cognitive impairment in a transgenic mouse model of Alzheimer amyloidosis.
    Uryu K; Laurer H; McIntosh T; Praticò D; Martinez D; Leight S; Lee VM; Trojanowski JQ
    J Neurosci; 2002 Jan; 22(2):446-54. PubMed ID: 11784789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abeta is targeted to the vasculature in a mouse model of hereditary cerebral hemorrhage with amyloidosis.
    Herzig MC; Winkler DT; Burgermeister P; Pfeifer M; Kohler E; Schmidt SD; Danner S; Abramowski D; Stürchler-Pierrat C; Bürki K; van Duinen SG; Maat-Schieman ML; Staufenbiel M; Mathews PM; Jucker M
    Nat Neurosci; 2004 Sep; 7(9):954-60. PubMed ID: 15311281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholinergic changes in the APP23 transgenic mouse model of cerebral amyloidosis.
    Boncristiano S; Calhoun ME; Kelly PH; Pfeifer M; Bondolfi L; Stalder M; Phinney AL; Abramowski D; Sturchler-Pierrat C; Enz A; Sommer B; Staufenbiel M; Jucker M
    J Neurosci; 2002 Apr; 22(8):3234-43. PubMed ID: 11943824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resting state FMRI reveals diminished functional connectivity in a mouse model of amyloidosis.
    Shah D; Jonckers E; Praet J; Vanhoutte G; Delgado Y Palacios R; Bigot C; D'Souza DV; Verhoye M; Van der Linden A
    PLoS One; 2013; 8(12):e84241. PubMed ID: 24358348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain Amyloidosis and BDNF Deficiency Have Opposite Effects on Brain Volumes in AβPP/PS1 Mice Both in vivo and ex vivo.
    Kärkkäinen E; Lahtinen HM; Närväinen J; Gröhn O; Tanila H
    J Alzheimers Dis; 2015; 46(4):929-46. PubMed ID: 26402627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RAGE does not affect amyloid pathology in transgenic ArcAbeta mice.
    Vodopivec I; Galichet A; Knobloch M; Bierhaus A; Heizmann CW; Nitsch RM
    Neurodegener Dis; 2009; 6(5-6):270-80. PubMed ID: 20145420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diffusion kurtosis imaging to detect amyloidosis in an APP/PS1 mouse model for Alzheimer's disease.
    Vanhoutte G; Pereson S; Delgado Y Palacios R; Guns PJ; Asselbergh B; Veraart J; Sijbers J; Verhoye M; Van Broeckhoven C; Van der Linden A
    Magn Reson Med; 2013 Apr; 69(4):1115-21. PubMed ID: 23494926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early alterations in functional connectivity and white matter structure in a transgenic mouse model of cerebral amyloidosis.
    Grandjean J; Schroeter A; He P; Tanadini M; Keist R; Krstic D; Konietzko U; Klohs J; Nitsch RM; Rudin M
    J Neurosci; 2014 Oct; 34(41):13780-9. PubMed ID: 25297104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and amyloid plaque targeting ability of a novel peptide-based magnetic resonance contrast agent in wild-type and Alzheimer's disease transgenic mice.
    Kandimalla KK; Wengenack TM; Curran GL; Gilles EJ; Poduslo JF
    J Pharmacol Exp Ther; 2007 Aug; 322(2):541-9. PubMed ID: 17505020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early pathologic amyloid induces hypersynchrony of BOLD resting-state networks in transgenic mice and provides an early therapeutic window before amyloid plaque deposition.
    Shah D; Praet J; Latif Hernandez A; Höfling C; Anckaerts C; Bard F; Morawski M; Detrez JR; Prinsen E; Villa A; De Vos WH; Maggi A; D'Hooge R; Balschun D; Rossner S; Verhoye M; Van der Linden A
    Alzheimers Dement; 2016 Sep; 12(9):964-976. PubMed ID: 27107518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intraneuronal APP and extracellular Aβ independently cause dendritic spine pathology in transgenic mouse models of Alzheimer's disease.
    Zou C; Montagna E; Shi Y; Peters F; Blazquez-Llorca L; Shi S; Filser S; Dorostkar MM; Herms J
    Acta Neuropathol; 2015 Jun; 129(6):909-20. PubMed ID: 25862638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.